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Abstract: This work demonstrates the feasibility of simultaneous discrimination of multiple con-
trast agents based on their element-specific and energy-dependent X-ray attenuation properties using
a pre-clinical photon-counting spectral CT. We used a photon-counting based pre-clinical spectral
CT scanner with four energy thresholds to measure the X-ray attenuation properties of various
concentrations of iodine (9, 18 and 36 mg/ml), gadolinium (2, 4 and 8 mg/ml) and gold (2, 4 and
8 mg/ml) based contrast agents, calcium chloride (140 and 280 mg/ml) and water. We evaluated
the spectral imaging performances of different energy threshold schemes between 25 to 82 keV at
118 kVp, based on K-factor and signal-to-noise ratio and ranked them. K-factor was defined as the
X-ray attenuation in the K-edge containing energy range divided by the X-ray attenuation in the
preceding energy range, expressed as a percentage. We evaluated the effectiveness of the optimised
energy selection to discriminate all three contrast agents in a phantom of 33 mm diameter. A
photon-counting spectral CT using four energy thresholds of 27, 33, 49 and 81 keV at 118 kVp
simultaneously discriminated three contrast agents based on iodine, gadolinium and gold at vari-
ous concentrations using their K-edge and energy-dependent X-ray attenuation features in a single
1Corresponding author.
c© 2018 CERN. Published by IOP Publishing Ltd on behalf of Sissa
Medialab. Original content from this work may be used under the terms
of the Creative Commons Attribution 3.0 licence. Any further distribution of this work
must maintain attribution to the author(s) and the title of the work, journal citation
and DOI.
https://doi.org/10.1088/1748-0221/13/02/T02001
2018 JINST 13 T02001
scan. A ranking method to evaluate spectral imaging performance enabled energy thresholds to be
optimised to discriminate iodine, gadolinium and gold contrast agents in a single spectral CT scan.
Simultaneous discrimination of multiple contrast agents in a single scan is likely to open up new
possibilities of improving the accuracy of disease diagnosis by simultaneously imaging multiple
bio-markers each labelled with a nano-contrast agent.
Keywords: Computerized Tomography (CT) and Computed Radiography (CR); X-ray detectors;
Image reconstruction in medical imaging; Medical-image reconstruction methods and algorithms,
computer-aided software
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1 Introduction
The ability to identify disease processes at the cellular or molecular level for diagnosis and treatment
remains a central goal for pre-clinical or clinical research. Because of the unique physical and
chemical properties of metallic nanoparticles, they are increasingly being used as targeted X-ray
contrast agents to yield functional information at the cellular level using computed tomography [1–
7]. Nano-sized X-ray contrast agents can deliver a large number of heavy atoms to a targeted region
of interest to increase the X-ray attenuation and sensitivity of X-ray detection. Spectral imaging,
integratedwith nanoparticleX-ray contrast agents and various active targeting strategies (also known
as spectral molecular imaging) has shown great promise toward providing quantitative information
in studies of the dynamics of biological processes and disease within a cell or tissue [6, 8–12]. For
example, tracking the cell in vivo [13] or detecting the macrophage content in an atherosclerotic
plaque [14] or monitoring drug delivery [15]. The ability to quantify and visualize molecular
biomarkers of a disease will enable tracking of the progression or regression of disease and aid in
refining personalized treatment strategies.
Many biological processes require simultaneous non-invasive identification and measurement
of their components. Different cells and biomarkers have X-ray attenuation properties so simi-
lar that they are intrinsically indistinguishable from each other. Biomarkers can be labelled with
different nano-contrast agents at biologically relevant concentrations to enhance their differentia-
tion in-situ. Spectral imaging sampling X-ray data from multiple X-ray energy ranges measures
the energy-dependent X-ray attenuation properties that allows discrimination and quantification
of materials [16, 17] of interest. The photo-electric effect is the dominant physical interaction
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mechanism of X-ray photons within diagnostic imaging energy range 30–120 keV and it is approx-
imately proportional to the third (or fourth) power of the atomic number. The presence of high-Z
nano-contrast agents can facilitate detection of biomarkers at low concentration typically present in
biological processes.
Material discrimination in spectral imaging is further enhanced by the presence of discontinuity
in the cross section of the photo-electric effect of high-Z contrast agents. This discontinuity in the
photo-electric cross section is called the K-edge. The K-edge feature is characteristic of an element
that occurs when the energy of incident X-ray photons matches to the binding energy of K-shell
electrons in an atom. None of the elements that naturally occur in a human body have a K-edge
that is accessible in the relevant diagnostic energy range. Exogenous high-Z contrast agents which
show distinct K-edge feature within the diagnostic energy range can be used to unambiguously
and specifically quantify elements within a biological specimen [18–21]. Spectral imaging with
multiple energy thresholds (minimum of two thresholds are required to capture the K-edge feature
of an element) allows capturing the K-edge features of several elements simultaneously.
The potential of spectral imaging to discriminate and quantifymultiple nano-contrast agents [11,
22, 23] within an image voxel allows targeting of multiple bio-markers simultaneously and gives an
opportunity for more sophisticated tissue characterisation. Detecting only a single tumor marker
is usually inadequate for an accurate diagnosis of cancer since most are not specific to a particular
tumor [24]. To improve the accuracy of cancer diagnosis, it is necessary to combine testing of mul-
tiple tumor markers as it could improve the diagnostic specificity [25, 26]. For example, detecting
multiple tumor bio-markers at an early stage in the clinical course facilitates diagnosis of cancer
and treatment monitoring [27, 28], which in turn significantly improves the treatment efficiency and
survival rates [29, 30].
In this paper, we demonstrate the feasibility of simultaneous discrimination of various concen-
trations of iodine (I), gadolinium (Gd) and gold (Au) based contrast agents, using their element-
specific and energy-dependentX-ray attenuation properties. We present amethodology to determine
the appropriate scanning energy thresholds in an energy-resolving photon-counting detector based
spectral CT. Four energy thresholds are used to measure the X-ray attenuation on either side of
K-edge features of I, Gd and Au. Optimal selection of scanning energy thresholds is needed to
balance the trade-off between energy information and signal-to-noise ratio (a measure that compares
the level of a desired signal to the level of background noise in the measurement). We introduce a
ranking method to evaluate the energy information and SNR at various scanning energy thresholds.
Then we select high ranked energy threshold schemes to demonstrate the feasibility of element-
specific spectral imaging for simultaneous discrimination of I, Gd and Au based contrast agents in
a single scan.
2 Materials and methods
2.1 Medipix based spectral CT imaging system: MARS scanner
A MARS scanner (Mars BioImaging Ltd, Christchurch, New Zealand) [31–33] is a pre-clinical
spectral imaging system, comprised of a MARS camera [34–37], a micro-focus X-ray source
(Source-Ray Inc, Ronkonkoma, NY, U.S.A.) and various mechanical components. The X-ray
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source used for this study has a tungsten anode, total filtration of 3.8 mm aluminium (equivalent)
and focal spot of ≈ 50 µm.
For this study, we used a MARS camera fitted with a detector module incorporating a
Medipix3RX ASIC [38] bump-bonded to a standard high resistivity 2 mm thick CdTe sensor.
The sensitive area of each chip was 1.408 × 1.408 cm2, which is subdivided into a 128 × 128 array
of pixels with a pitch of 110 µm. The CdTe sensor layer was configured as a pn-junction diode
supplied with a negative high-voltage bias (-600 V) for collection of electrons. The counter depth
of 12-bit provides a dynamic range of 0–4095 counts per pixel.
In X-ray detectors with small pixels (<500 µm), the charge collected from a single photon
interaction is spread across several neighbouring pixels. This effect is known as the charge sharing
effect. TheMedipix3RX chip implements a charge summing circuit to correct for the charge sharing
effect by processing the charge collected by the pixel matrix using a 2 × 2 pixel substructure with
inter-pixel communication. This correction preserves both the spatial and spectral information of
individual photons. Further details of working of Charge Summing Mode (CSM) in Medipix3RX
can be found elsewhere [38].
The CdTe-Medipix3RX is a high-Z sensor based energy-resolving detector which has four
spectrum-distortion corrected energy thresholds per pixel. Physically, the energy thresholds are
realised by setting the reference threshold of the pulse-height comparator circuit of all pixels in
the matrix. The pulse height obtained from the interaction of an X-ray photon with the sensor is
proportional to the energy of the detected photon. The relationship between the measured photon
energy and the applied energy thresholds (energy calibration) for the energy-resolving detector used
in this paper was established according to Panta et al. [37].
2.2 Determination of scanning energy thresholds
Discrimination of elements in an object using photon-counting spectral CT requires judicious
selection of energy thresholds. This is due to the trade-off between energy-dependent information
and signal-to-noise ratio (SNR) within an energy range. A narrow energy range preserves the
energy-dependent information, such as K-edge feature of an element, whereas in a wide energy
range, the K-edge feature is washed out due to data averaging. Conversely, SNR in an image is
greater for a wider energy range. This contradictory requirement of energy information and SNR
needs to be taken into account when selecting the width of energy ranges.
A commonly used technique [41] to select the appropriate width of energy range for measuring
the K-edge feature of an element is based on signal difference to noise ratio (SDNR) where the
signal difference is defined between reconstructed target region values on either side of the K-edge
feature. The limitation of this technique is that it has only been studied using an ideal detector
within simulation framework. In practice, the subtraction of reconstructed images amplifies the
noise in the resultant image which adversely affects the energy information.
In this study, we have introduced the “K-factor” as an indicator of energy information provided
by the K-edge of an element:
K-factor =
X-ray attenuation at K-edge-containing energy range
X-ray attenuation at preceeding energy range
× 100% (2.1)
In contrast to the SDNR measurement technique [41], the K-factor method reduces the uncer-
tainty of energy information as we are calculating the ratio of X-ray signal on either side of the
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Figure 1. X-ray mass attenuation profiles [39] for iodine, gadolinium and gold with corresponding K-edge
at 33.2 keV, 50.2 keV and 80.7 keV respectively, and X-ray emission spectrum [40] obtained from an X-ray
tube operating at 118 kVp. The choice of energy thresholds for K-edge imaging is the trade-off between
energy information (depends on mass attenuation profiles) and signal-to-noise ratio (depends on X-ray
source spectrum).
K-edge feature. A higher K-factor implies that higher energy information has been preserved by
reducing the wash out effect on the K-edge feature. The higher the K-factor, the better the energy
(spectroscopic) information. Similarly, the higher the intensity of X-ray photons (X-ray intensity is
defined as total number of photons/area/time) in an energy range, the better the SNR of an image
in that energy range while using the same spectrum (or radiation dose). Figure 1 shows the X-ray
spectrum (120 kVp and 3.8 mm Al thickness), and mass attenuation coefficient of I, Gd and Au as a
function of photon energy. K-edges of I, Gd and Au are apparent at 33.2, 50.2 and 80.7 keV respec-
tively. The X-ray spectrum was generated using SpekCalc program [42] and the mass attenuation
coefficient of I, Gd and Au were generated using Photon Cross sections Database [43].
The spectral camera in a MARS scanner uses a CdTe-Medipix3RX detector [38] which has
four adjustable energy thresholds for correcting spectrum-distortion on each individual pixel. These
four energy thresholds need to be selected judiciously on either side of the K-edges of I, Gd and
Au for capturing them on spectral scan. Table 1 shows examples of five different possible energy
threshold schemes for each element and the trade-off between energy information (K-factor) and
relative X-ray intensity (X-ray intensity in a particular energy range ×100%/ X-ray intensity in
all energy ranges or entire X-ray spectrum). The higher the relative X-ray intensity, the higher
the quantum signal-to-noise ratio. For example, in Scheme D for iodine, the selection of energy
ranges of 27–33 keV and 33–49 keV provides a maximum K-factor (668 %), however, relative X-ray
intensity (29 %) in K-edge containing energy range (33–49) is the poorest among five schemes.
Based on K-factor and relative X-ray intensity in the K-edge containing energy range, a rank was
assigned to each of these schemes as shown in table 1.
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Table 1. Determination of ranks for various potential combination of energy thresholds based onK-factor and
relative X-ray intensity performance in K-edge containing energy range for I, Gd andAu based contrast agents.
K-factor Relative X-ray
intensity
Element Scheme Energy range (keV) Value (%) Rank Value (%) Rank
A 19–32, 32–52 204 3 35 2
B 25–35, 35–55 248 2 35 2
Iodine
(K-edge at 33.2 keV)
C 21–35, 35–54 161 5 33 3
D 27–33, 33–49 668 1 29 4
E 20–35, 35–60 167 4 49 1
A 32–52, 52–83 185 2 42 2
B 35–55, 55–82 139 4 37 4
Gadolinium
(K-edge at 50.2 keV)
C 35–54, 54–85 172 3 40 3
D 33–49, 49–81 287 1 46 1
E 35–60, 60–85 79 5 23 5
A 52–83, 83–118 146 4 11 2
B 55–82, 82–118 193 2 12 1
Gold
(K-edge at 80.7 keV)
C 54–85, 85–118 130 5 10 3
D 49–81, 81–118 204 1 12 1
E 60–85, 85–118 170 3 10 3
Table 2. Determination of best energy threshold scheme for simultaneously discriminating the K-edge
features of I, Gd and Au based on ranking. Overall rank for various schemes of energy thresholds was
determined based on K-factor and relative X-ray intensity performance as shown in table 1. Top two
rated schemes (Scheme B and Scheme D) are selected for evaluating their spectral imaging performance to
discriminate all three contrast agents (I, Gd and Au) simultaneously.
Scheme Energy range (keV) Overall rank
A 19–32, 32–52, 52–83, 83–118 2
B 25–35, 35–55, 55–82, 82–118 2
C 21–35, 35–54, 54–85, 85–118 4
D 27–33, 33–49, 49–81, 81–118 1
E 20–35, 35–60, 60–85, 85–118 3
Based on the combination of individual rank of each scheme for all elements (I, Gd and Au),
an overall rank was determined as shown in table 2. For example, Scheme D has the highest
overall rank (1) because the combination of individual rank based on the K-factor and relative X-ray
intensity ranks for all three elements is better than that of the schemes (A, B, C & E).
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Figure 2. A schematic of multi-contrast phantom filled with various concentrations of Omnipaque (iodine
based), Magnevist (gadolinium based) and gold nano-particle (AuNP) contrast agents, water and calcium
chloride solutions (Not to scale).
For evaluating the spectral imaging performance of top two ranked energy threshold schemes
(Scheme B and Scheme D in table 1) in simultaneous discrimination of the K-edge features of I, Gd
and Au, spectral imaging of a multi-contrast phantom was performed.
2.3 A multi-contrast phantom
A multi-contrast phantom (diameter of 33 mm) was fabricated for performing element-specific
spectral imaging. Using commercially available iodine-based Iohexol (Omnipaque, GE Health-
care, Princeton, NJ), gadolinium-based gadopentate dimeglumine (Magnevist, Bayer Healthcare,
Whippany, NJ) and 2nm gold nanoparticles (Aurovist, Nanoprobes, Yaphank, NY) contrast agents,
multiple inserts (diameter of 8 mm) were filled with various concentrations of iodine (9, 18 &
36 mg/ml), gadolinium (2, 4 & 8 mg/ml) and gold (2, 4 & 8 mg/ml) based contrast agents, and
calcium-chloride (140 & 280 mg/ml) as a surrogate of bone, and water as a surrogate of soft tissue.
A schematic of multi-contrast phantom is shown in figure 2.
2.4 Spectral imaging
Spectral CT images of a multi-contrast phantom were acquired using a MARS scanner equipped
with an energy-resolving detector (CdTe-Medipix3RX). The settings used for spectral imaging are
summarised in table 1. The X-ray tube was operated at 118 kVp and the detector was operated in
spectrum-distortion-corrected spectroscopic mode. Flat field images (with no object in the beam)
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Table 3. Technical settings for spectral CT scan.
Scan geometry Cone beam
Phantom inserts iodine (9, 18, 36 mg/ml), gadolinium (2, 4, 8
mg/ml), gold (2, 4, 8 mg/ml), Water, calcium
(140, 180 mg/ml)
X-ray detector CdTe-Medipix3RX
Camera mode of operation Spectroscopic CSM (Charge Summing Mode)
Magnification factor 1.34
Detector pixel pitch (µm) 110
X-ray exposure 118 kVp, 27 µA, 120 ms
Total filtration (Al) (1.8 mm (inherent) + 2 mm (added))
Energy ranges (keV) for Scheme B 25–35, 35–55, 55–82, 82–118
Energy ranges (keV) for Scheme D 27–33, 33–49, 49–81, 81–118
Focal spot size (µm) ≈ 50
Reconstruction algorithm Ordered Subset Expectation Maximization
(OSEM)
Reconstruction voxel size (µm3) 180 × 180 × 180
Slice thickness at isocenter (µm) 241
were acquired before and after scanning the multi-contrast phantom. Spectrally resolved images
determined by the chosen scheme, were collected simultaneously.
The projection data in each energy range was flat field corrected, processed, and reconstructed
simultaneously using Ordered Subset Expectation Maximization (OSEM) technique with voxel
dimensions of 180 × 180 × 180 µm3. The slice thickness at isocenter was 241 µm.
Spectral imaging performance of the two highest ranked schemes (Scheme B and Scheme D in
table 3) were evaluated by comparing the energy information (K-factor) and QSNR for each element
individually. Mass attenuation coefficient for each high-Z element was calculated for estimating the
K-factor of both schemes. Flat field images (720 images in total) for each scheme were averaged to
calculate the SNR at K-edge-containing energy ranges for each element individually.
For further data analysis, voxel values (absolute X-ray attenuation or linear attenuation co-
efficient (cm−1) of the reconstructed CT image were transformed to relative X-ray attenuation in
Hounsfield Units (HU) using equation 2.2:
HUvoxel =
µvoxel − µwater
µwater − µair × 1000 (2.2)
where HUvoxel is the HU of the voxel, the µvoxel, µwater, µair are linear attenuation coefficient of the
voxel, water and air in the reconstructed image, respectively.
For the measurement of the relative X-ray attenuation (HU) of different regions of interest
(ROIs) containing contrast agents, the mean value and standard deviation (σ) within a circular ROI
comprising≈ 300 voxels (N) were measured. The standard error of X-ray attenuation was calculated
as σ√
N
.
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2.5 Material decomposition
Material decomposition (MD) algorithm in spectral CT exploits the energy dependence of X-
ray attenuation of each voxel inside the object from multiple energy ranges to determine the
basis materials in the reconstructed material volume. Material decomposition based on the MARS
constrained linear least square algorithm [44] was used on reconstructed images using the subtracted
energy ranges. MARSMD algorithm splits the total attenuation coefficient into the individual X-ray
attenuation of several predefined basis materials for a given energy. Based on the pattern of X-ray
attenuation of variousmaterials atmultiple energy ranges,MDassigns the voxel to the corresponding
material. Thus MD algorithm generates the basis material image on a voxel-by-voxel basis.
3 Results
3.1 Evaluation of spectral imaging performance
K-factor and SNR were used as metrics to compare the spectral imaging performance at different
scanning energy thresholds. Figure 3(a) shows that K-factor of Scheme D (energy range: 27–33,
33–49, 49–81 and 81–118 keV) is higher than that of Scheme B (energy range: 25–35, 35–55,
55–82 and 82–118 keV) for all three elements (I, Gd ad Au). Similarly, figure 3(b) shows that
SNR of Scheme D is slightly higher than that of Scheme B for K-edge containing energy ranges of
gadolinium and gold, but lower for iodine. The spectral imaging performance of both schemes is
consistent qualitatively with theoretical spectral imaging performance as presented in table 2. This
shows that spectral imaging performance of Scheme D is marginally better than Scheme B. Further
data analysis comprises only the spectral data acquired using Scheme D.
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Figure 3. Evaluation of spectral imaging performance of two energy schemes (Scheme B (energy range: 25–
35, 35–55, 55–82 and 82–118 keV) and Scheme D (energy range: 27–33, 33–49, 49–81, 81–118 keV) which
are rated 2 & 1 respectively as shown in table 2) based on K-factor (energy information) and signal-to-noise
ratio (SNR). Figure 3(a) shows that Scheme D has higher K-factor for iodine, gadolinium and gold based
contrast agents. Similarly, figure 3(b) shows that Scheme D has better SNR for gadolinium and gold based
contrast agents than Scheme B. However, Scheme B has better SNR for iodine based contrast agents. Based
on K-factor and SNR for all contrast agents, Scheme D has marginally better spectral imaging performance.
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Figure 4. Spectral CT images of multi-contrast phantom containing iodine (9, 18 & 36 mg/ml), gadolinium
(2, 4 & 8 mg/ml) and gold (2, 4 & 8 mg/ml) based contrast agents, and bone-like material (calcium-chloride
of 140 & 280 mg/ml), and soft tissue-like (water) material at different energy ranges. X-ray attenuation
values of each voxel is shown in Hounsfield Unit (HU).
3.2 Discrimination of multiple K-edges
Spectral CT images acquired using Scheme D are shown in figure 4. The images acquired in four
distinct energy ranges are shown. The spectral CT images of multi-contrast phantom including
iodine (9, 18 & 36 mg/ml), gadolinium (2, 4 & 8 mg/ml) and gold (2, 4 & 8 mg/ml) based contrast
agents, and calcium-chloride (140 & 280 mg/ml) as surrogate for bone, and water as surrogate
for soft tissue are shown in figure 4. Each CT image in each energy range possesses unique
energy-dependent X-ray attenuation values. The presence of ring artifacts is visible, these are due
to inconsistency of signal collection in some pixels during scanning.
The performance of the imaging scheme was assessed for different concentrations of each
contrast agent. Figures 5(a)–5(c) present the mean values of relative X-ray attenuation (HU) within
different concentrations of I, Gd andAu contrast agents. Themean valueswere calculated over≈ 300
voxels in each ROI. The standard error of X-ray attenuation within different ROIs was ± 7–35 HU.
X-ray attenuation of all contrast agents at all concentrations is maximal for the K-edge-containing
energy range, in which the attenuation is greater than that in the preceding and succeeding energy
range. X-ray attenuation is maximum for all concentrations of iodine, gadolinium and gold at
33–49 keV, 49–81 keV and 81–118 keV respectively. This is because of the K-edge effect of the
corresponding element. The maximum K-factors for I, Gd and Au were 157 %, 153 % and 125 %
respectively. These results show that each of the K-edges for I, Gd and Au based contrast agents
can be discriminated using spectral CT.
3.3 Material decomposition
The basis material image was generated by expressing the energy-dependent X-ray attenuation
in each image voxel as a linear combination of the X-ray attenuation of several predefined basis
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Figure 5. (a) Relative X-ray attenuation of various concentrations of iodine based contrast agent showing
K-edge enhancement at 33–49 keV (b) Relative X-ray attenuation of various concentrations of gadolinium
based contrast agent showing K-edge enhancement at 49–81 keV (c) Relative X-ray attenuation of various
concentrations of gold based contrast agent showing K-edge enhancement at 81–118 keV. The standard error
in themeasurement of relative X-ray attenuation of various concentrations of contrast agents is± 7–35HU. (d)
Material decomposed basis image based on MARS constrained linear least square algorithm to differentiate
water, iodine, gadolinium, gold and calcium contrast agents. The material decomposed image is based on
the same energy range selection as in 5(a)–5(c). Purple: iodine at 9, 18, 36 mg/ml; green: gadolinium at 2,
4, 8 mg/ml; yellow: gold at 2, 4, 8 mg/ml and White: calcium at 140, 180 mg/ml.
materials (water, I, Gd, Au, Ca). Figure 5(d) shows the basis image which decomposes: water,
iodine, gadolinium, gold and calcium based contrast agents based on their energy-dependent X-ray
attenuation properties. A different false color was assigned to each of the decomposed materials.
The higher the concentration of materials, the brighter the color display.
4 Discussion
Spectral X-ray imaging is being developed as a new X-ray imaging modality due to its unique
ability to provide specific and quantitative material information. This allows tissue-type specific
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imaging. If spectral imaging is integrated with targeting of biomarkers, simultaneous functional and
anatomical tomographic images in a single scan, that is quantitative molecular imaging, becomes
possible. In this paper, we demonstrated simultaneous discrimination of element-specific K-edge
features and energy-dependent X-ray attenuation features of commercially available I, Gd and Au
based contrast agents in a single scan. We developed a ranking methodology to determine the
appropriate scanning energy thresholds in an energy resolving detector by balancing the trade-off
between energy information and signal-to-noise ratio.
Near-term applications of element-specific spectral imaging of high-Z contrast agents could
be in in-vivo molecular imaging of atherosclerosis or cancer in a mouse model. The importance of
discriminating multiple K-edge features lies in the possibility to simultaneously identify and locate
the disease (by using specific functionalised nano-particles to target the bio-markers of a disease),
the immune response using nano-particles specific to the immune cell (e.g. macrophages), and drug
delivery in a single scan. Furthermore, the ability to discriminate more than one high-Z contrast
agent may have clinical relevance in simultaneous selective enhancement of different regions. For
example, the entire cardio-vascular systemmight be enhancedwith a blood-pool contrast agentwhile
atherosclerotic plaques might be identified with a different high-Z material nanoparticle targeted to
biomarkers of atherosclerotic lesions like the necrotic lipid core or intraplaque hemorrhage.
Simultaneous imaging ofmultiple biomarkers in vivo has been achieved using quantumdots [24,
45], a new form of fluorescent label. There are many nanoparticle cancer therapies approved for
clinical use [46]. Translating metal nano-contrast agents to in vivo clinical applications whether as
purely diagnostic agents or combined with therapy (theranostic agents) is a difficult task and fraught
with regulatory hurdles. There aremany nanoparticle cancer therapies approved for clinical use [46].
At least three metal nanomedicines have completed clinical trials [47] and iron, silica and gold based
nanoparticles are undergoing clinical trials [46]. Gold is the most extensively studied nanocontrast
agent [48] but manymore metal based nanocontrast agents are being investigated including bismuth,
platinum, hafnium, yytterbium, tantulum, and yttrium [11]. An effort to combine functionality in
nanoparticles has been pursued by some in part because of the difficulty in getting nanocontrast
agents approved. This approach has led to the development of nanoparticles with combinations of
iron, gold, fluorophores, radiotracers, gadolinium, manganese are suitable for multimodal imaging
by combinations of MR, CT, PET, SPECT, ultrasound and optical imaging [49–51].
To readily identify a specific element by using its K-edge feature in spectral imaging, the
energy ranges should be narrow but well separated. Each energy range should be narrow enough to
preserve energy information (or K-factor) but should be wide enough to provide adequate signal-
to-noise ratio. Moreover, the global spectral resolution of a detector is also a limiting factor for
the minimal practical energy width of an energy range. The finite global spectral resolution of a
detector broadens the energy borders and increases the cross-talk effect between adjacent energy
ranges. So, for K-edge imaging, selecting the right energy thresholds or width of an energy
range is a trade-off between energy information and signal-to-noise ratio. This study introduced
and validated a ranking methodology to evaluate the spectral imaging performance of various
combination of energy thresholds schemes based on energy information and SNR. Similarly, by
selecting appropriate energy thresholds, simultaneous discrimination of multiple K-edge features of
I, Gd andAu based contrast agents was demonstrated. Thismethodology of determining appropriate
energy thresholds presented in this paper is not limited to only I, Gd and Au based contrast agents
but can be easily extended to other element based contrast agents as well.
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The key property of a contrast agent that determines the magnitude of X-ray attenuation is the
atomic number (Z). The higher the Z of a contrast agent, the greater the X-ray attenuation. The
greater the differential attenuation, the easier to separate the contrast agent from other materials
including other contrast agents. Three high-Z elements used in this study are: iodine (Z = 53),
gadolinium (Z = 64) and gold (Z = 79). A contrast agent should ideally have high X-ray attenuation
at low concentrations, sufficient to enhance image contrast within the imaging energy range. Since
the K-edge of iodine (at 33.2 keV where X-ray attenuation increases abruptly) lies near to the
lower energy border of the human diagnostic energy range, iodine is not an ideal contrast agent
for human imaging because of photon starvation (causes poor signal-to-noise ratio) at the K-edge
region. Similarly, relatively few photons are produced by X-ray sources used in human CT above
the 80.7 keV K-edge of gold, which reduces the sensitivity of K-edge discrimination. On the other
hand, human CT has a relative abundance of photons above the Gadolinium K-edge of 50.2 keV
which increases the sensitivity of K-edge discrimination.
The K-edge discrimination using a spectral imaging system also depends on many parameters
such as spectral characteristics and noise performance of an energy resolving detector, scattered
radiation on the measured X-ray spectrum, atomic number of sensor materials, size of the sample,
and X-ray tube settings and filtration. To provide sufficient sensitivity at the molecular level, these
factors need to be taken into account.
Summary and conclusion. We demonstrated the feasibility of simultaneous discrimination of
multiple contrast agents by exploiting their element-specific (K-edges) and energy-dependent X-ray
attenuation properties in a single scan using a pre-clinical photon-counting spectral CT (MARS
scanner). A ranking methodology for selecting appropriate scanning energy thresholds in an energy
resolving detector was developed and used to measure the K-edge features of various concentrations
of iodine, gadolinium and gold based contrast agents. The ability to simultaneously discriminate
multiple contrast agents at the concentrations relevant to biomedical application is likely to open up
new possibilities for imaging multiple functional processes in a single scan.
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